AINewsIQ by Triuna Labs
Menu
SOURCE-LINKED SIGNAL / DISCUSSION / INDUSTRY

Why I'm growing my Vancouver AI company in Taiwan and Europe instead of the U.S.

Al Vigier, CEO of Vancouver AI company Caseway, explains why the firm is growing in Taiwan and Europe rather than the U.S. after withdrawing from a Silicon Valley accelerator. He cites a U.S. directive telling agencies to remove Canadian-made products from schedules, which stopped new U.S. business development while keeping existing registrations and two American customers. Caseway reports signed agreements and pilots in Taiwan, including a drone-software partnership with Kunway Technology, with revenue not yet realized there. He also describes European defence procurement opportunities under Canada's SAFE agreement.

Open original source bcbusiness.ca
Recorded links

One primary source; other links are context, not independent corroboration.

A community post points to the original link. Discussion and upvotes do not establish accuracy.

How this score was derived
  • Community discussion+5
  • Fetched source page+30
  • No editor link review0
  • Community link0

This measures the stored source trail and editorial steps. It does not certify accuracy, peer review, or independent corroboration. Popularity adds no points.

View full scoring →Read the scoring rubric →

What the source says

Al Vigier, CEO of Vancouver AI company Caseway, explains why the firm is growing in Taiwan and Europe rather than the U.S. after withdrawing from a Silicon Valley accelerator. He cites a U.S. directive telling agencies to remove Canadian-made products from schedules, which stopped new U.S. business development while keeping existing registrations and two American customers. Caseway reports signed agreements and pilots in Taiwan, including a drone-software partnership with Kunway Technology, with revenue not yet realized there. He also describes European defence procurement opportunities under Canada's SAFE agreement.

How to read this signalSix questions about claims, sources, risks, and open checks

This is a signal-level guide until claim-level evidence is available. “Not recorded” means the evidence has not been assessed here; it does not mean a result is false. How we check AI news →

  1. 01
    Who is making each claim?

    The claimant and whether each claim was measured or asserted are not recorded in this public brief.

  2. 02
    What was actually tested?

    Not recorded per claim. Check the source for sample size, tasks, model and benchmark versions, and reproducibility.

  3. 03
    Where are the sources?

    Original link: bcbusiness.ca. Brief basis: fetched source page. Primary page date and quote locations are not established in this panel.

  4. 04
    What could mislead?

    Source claims not independently checked; the account is a guest opinion by the company's CEO describing his own firm's plans and deals.

  5. 05
    What is at risk if wrong?

    Not assessed per claim. Consider safety, privacy, cost, and adoption decisions before relying on the result.

  6. 06
    What would change the view?

    No claim-specific check is recorded. An inspectable primary method or independent replication could change the assessment.

Key findings from the stored brief

  • Caseway stopped new U.S. business development after a September 8 directive told American agencies to remove Canadian-made products from procurement schedules.
  • Caseway's revenue currently comes from courts and law firms; Taiwan activity consists of signed agreements and scoped pilots, not yet revenue.
  • A planned Taiwan partnership with drone maker Kunway involves a paid pilot, supplied hardware, then a per-unit licence and revenue share, with an MOU being finalized.
  • Caseway says its defence customers wanted software to run on their own hardware under their own law, which made a U.S. expansion harder to reconcile.
Read with care

Source claims not independently checked; the account is a guest opinion by the company's CEO describing his own firm's plans and deals.

This is a source-based abstract, not independent validation of the source's claims.

Discussion

Comments are reviewed before publication. Discuss the evidence, not the person.

No published comments yet.

Reader discussion opens with accounts. You can read the original source and published comments now.